The global medical industry experienced a 35% drop in company filings mentions of cybersecurity in Q3 2023 compared with the previous quarter, with the highest share accounted for by Becton Dickinson and Co with 7200% year-on-year increase, according to GlobalData’s analysis of over 142 medical company filings. GlobalData’s Medical Devices: Filings Trends & Signals Q3 2023 report delves into earnings call transcripts and quarterly reports within the industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events. Buy the report here.
Notably, cybersecurity was one of the most frequently referenced themes in Q3 2023, ranking highest in terms of mentions, ahead of artificial intelligence and sharing economy, according to GlobalData.
Of the top leading companies in the medical industry, Becton Dickinson and Co had the greatest increase in references for cybersecurity in Q3 2023, compared with the previous quarter. GlobalData identified 73 cybersecurity-related sentences in the company's filings - 3% of all sentences - and an increase of 7200% in Q3 2023 compared with Q3 2022. DexCom’s mentions of cybersecurity rose by 12% to 37 and Danaher’s by 26% to 23 and Henry Schein’s by 9% to 21.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cybersecurity in Q3 2023 was 105.
For further understanding of GlobalData's Medical Devices: Filings Trends & Signals Q3 2023, buy the report here.